Portrait de Mikel Orobengoa

Organización: 

ISEA

Sphero And Ollie Robotic Toy Maker Orbotix Has Raised Another $20M, Say Sources

Orbotix, the company that makes fast-moving, robotic toys that you control with smartphone apps, has raised another $20 million in funding, TechCrunch has learned and confirmed with a reliable source. This brings the total raised by maker of the popular Sphero ball to $35 million, as it gears up to start selling its next product, the cylindrical Ollie (originally called the 2B), later this year (pictured here).

Galileo Master, el concurso europeo que premia ideas y proyectos de geolocalización, presenta la edición 2014.

La Diputación de Gipuzkoa y el Departamento de Desarrollo Económico y Competitividad del Gobierno Vasco abren la convocatoria 2014 para Euskadi del programa de proyectos e ideas de geolocalización Galileo Master. El objetivo es recoger ideas y proyectos de tecnologías de navegación y aplicaciones de localización que puedan tomar parte en el certamen europeo y que, posteriormente puedan ser patentados, desarrollados y comercializados.

Esta iniciativa, en la que participa Gipuzkoa junto a 23 regiones y países europeos, reúne a la comunidad de expertos internacionales en tecnologías de la navegación y las aplicaciones basadas en localización (LBS).

Jakiberri busca ideas para crear la cocina vasca Fast Food saludable.

La iniciativa Jakiberri consiste en la ideación y desarrollo de una nueva línea de comida rápida de origen vasco que sea saludable, variada y de calidad. Para dar con esta nueva etiqueta Healthy Basque Fast Food, este proyecto tiene en marcha la segunda edición de su Concurso de Ideas Jakiberri, abierto a la participación de toda la ciudadanía. Se pueden presentar propuestas hasta el 30 de mayo.

50 billion devices: How software has to change to fit an ultra-connected world.

Cisco thinks that as many as 50 billion devices will be connected to the Internet by 2020.

To put that in perspective, that’s nine devices for every one of the eight billion people expected to be on the planet. Your phone, the fitness device on your wrist, your doorbell, the thermostat in your hallway, the smart TV in your living room, the car in the driveway, the Amazon package at your doorstep, and even your family pet — all connected to the world and beaming data home.

Israeli lab develops blood test to detect breast cancer.

Miami-based medical technology company with an R&D subsidiary in Moshav Ora, near Jerusalem, has developed an easy, non-invasive method to detect breast cancer early on – using a simple blood test.

In its laboratories near the capital, Eventus Diagnostics (EventusDx) has developed what it describes as an accurate, cost-effective, immune system-based means of detecting the presence of cancer in the breast tissue.

The Octava tests, which measure cancer-specific antibodies produced by the immune system in response to the growth of tumors, can be used to quickly diagnose breast cancer and identify false negative mammogram results.

SOLS, Maker Of 3D-Printed Shoe Insoles, Raises $6.4M Series A.

SOLS, a 3D-printing company which is today focused on custom printed shoe insoles that help with foot pain and other ailments, has raised $6.4 million in Series A funding, in a round again led by the startup’s seed investor lead, Lux Capital. In addition, new investor Founders Fund also participated, along with existing investors RRE, Rothenberg Ventures, Felicis Ventures, FundersGuild, and Grape Arbor VC.

Previously, SOLS had raised $1.75 million in seed funding.

‘Sweet’ Success For Israeli Researchers In The Treatment And Early Detection Of Diabetes.

Here’s a not-so-sweet fact: According to the American Diabetes Association, one in three American adults will be diagnosed with diabetes by the year 2050 if present trends continue. The disturbing possibility of such a widespread phnomenon is what motivated two Israeli researchers to seek out more effective methods of treating and detecting the forthcoming high blood sugar epidemic.

Both Dr. Eli Lewis of Ben Gurion University and Dr. Nataly Lerner of Tel Aviv University’s Sackler Faculty of Medicine made recent breakthroughs individually, first in the treatment of Type I diabetes, or juvenile diabetes, then in the early detection of Type II diabetes, or adult-onset diabetes, using a blood test (respectively).

Groups Mikel contributes to

Suivi

This person isn't following anyone.